Findings from Integrated Behavioral and Biologic Survey among males who inject drugs (MWID)-Vietnam, 2009-2010: Evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Nadol, Patrick ^a,b   O'Connor, Siobhan ^a   Duong, Hao ^a   Le, Linh Vi N ^a   Thang, Pham Hong ^c   Tram, Tran Hong ^c   Ha, Hoang Thi Thanh ^c   McConnell, Michelle S ^a   Partridge, Jeff ^a   Kaldor, John ^b   Law, Matthew ^b   Nguyen, Tuan Anh ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c National Institute of Hygiene and Epidemiology   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN;

ADULT; AGE DISTRIBUTION; BEHAVIOR; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; FAMILY SIZE; HEALTH CARE NEED; HEALTH STATUS; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALES WHO INJECT DRUGS; MIXED INFECTION; NONHUMAN; PREVALENCE; QUESTIONNAIRE; REVIEW; SEXUAL BEHAVIOR; TREATMENT RESPONSE; VIET NAM; VIRAL PLAQUE ASSAY; VIRUS TRANSMISSION; HIV INFECTIONS; RISK FACTOR; SUBSTANCE ABUSE; VIROLOGY; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADULT; CROSS-SECTIONAL STUDIES; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SURVEYS AND QUESTIONNAIRES; VIETNAM; YOUNG ADULT;

EID: 84923307944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118304     Document Type: Review

References (45)

1. Sulkowski MS. Viral hepatitis and HIV coinfection. J. Hepatol. 2008;48(2):353-67. doi: 10.1016/j.jhep. 2007.11.009 PMID: 18155314
2. Quan VM, Go VF, Nam Le V, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care 2009;21(1):7-16. doi: 10.1080/09540120802017610 PMID: 19085215
3. Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011;378(9791):571-83. doi: 10.1016/S0140-6736 (11) 61097-0 PMID: 21802134
4. Perz JF, Armstrong GL, Farrington L A, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 2006;45(4):529-38. doi: 10.1016/j.jhep. 2006.05.013 PMID: 16879891
5. World Health Organization. Global policy report on the prevention and control of viral hepatitis in WHO member states. 2013. doi: 10.1016/j.jhep. 2013.06.029 PMID: 23850942
6. Prevention C for DC and. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Mmwr Morb. Mortal. Wkly. Rep. 1998;47(No. RR-19).
7. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: fi ndings from the Global Burden of Disease Study 2010. Lancet 2013;6736(13):1-11. doi: 10.1016/S0140-6736 (13) 61530-5
8. Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int. J. Epidemiol. 2004;33(1):182-8. doi: 10.1093/ije/dyh019 PMID: 15075167
9. Kim AY, Onofrey S, Church DR. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J. Infect. Dis. 2013;207 Suppl (Suppl 1):S1-6. doi: 10.1093/infdis/jis927
10. Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin. Infect. Dis. 2012;55 Suppl 1(Suppl 1:):S33-42. doi: 10.1093/cid/cis367 PMID: 22715212
11. World Health Organization. Guidance on Prevention of Viral Hepatits B and C Among People Who Inject Drugs.; 2012.
12. Hernando V, Perez-Cachafeiro S, Lewden C, et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J. Hepatol. 2012;57(4):743-51. doi: 10.1016/j.jhep. 2012.06.010 PMID: 22709620
13. Weber, Sabin R, Friis-Moller N CA et al. Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus. Arch Intern Med 2006;166:1632-1641. PMID: 16908797
14. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008;372(9651):1733-45. doi: 10.1016/S0140-6736 (08) 61311-2 PMID: 18817968
15. Vietnam Ministry of Health. Viet Nam HIV/AIDS Estimates and Projections 2011-2015.; 2012.
16. Nguyen V T T. Hepatitis B infection in Vietnam: current issues and future challenges. Asia. Pac. J. Public Health 2012;24(2):361-73. doi: 10.1177/1010539510385220 PMID: 21159700
17. Sereno L, Mesquita F, Kato M, Jacka D, Nguyen TT Van, Nguyen TN. Epidemiology, Responses, and Way Forward: The Silent Epidemic of Viral Hepatitis and HIV Coinfection in Vietnam. J. Int. Assoc. Physicians AIDS Care (Chic). 2012;11(5):311-20. doi: 10.1177/1545109712453939 PMID: 22828983
18. Nguyen CH, Ishizaki A, Chung PTT, et al. Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam. J. Med. Virol. 2011;83(3):399-404. doi: 10.1002/jmv. 21978 PMID: 21264859
19. Vietnam Ministry of Health NI of H and E. Integrated Biological and Behavioral Surveillance (IBBS) in Vietnam-Round II 2009.; 2011.
20. DiaSorin S.p. A. Technical Assay Details and Performance Summary: Murex HBsAg v. 3.; 2013. doi: 10. 1016/j.jfo.2013.06.003 PMID: 25632406
21. DiaSorin S.p. A. Technical Assay Details and Performance Summary: Murex HCV Ag/Ab Combination.; 2013. doi: 10.1016/j.jfo.2013.06.003 PMID: 25632406
22. Mark S. Handcock Ian E. Fellows K J G. Deducer RDSAnalyst: Graphical User Interface to the RDS package for Respondent-Driven Sampling., Version 0.1, Available: http://hpmrg.org. 2012.
23. Giles K, Handcock MS. Respondent-Driven Sampling: An Assessment of Current Methodology. Sociol. Methodol. 2010;40(1):1-34. doi: 10.1111/j.1467-9531.2010.01223.x
24. Vietnam Ministry of Health (MOH). Vietnam HIV/AIDS Estimates and Projections.; 2012.
25. Volz E, Wejnert C, Cameron C, et al. Respondent-Driven Sampling Analysis Tool (RDSAT). Respondent-Driven Sampl. Anal. Tool Version 7.1. Ithaca, NY Cornell Univ. 2012. Available: http://www.respondentdrivensampling.org/. Accessed 2013 August 14.
26. StataCorp. Stata Statistical Software: Release 12. 2011.
27. Ameringer S, Serlin RC, Ward S. Simpson's Paradox and Experimental Research Suzanne. Nurs Res 2009;58(2):123-127. doi: 10.1097/NNR.0b013e318199b517 PMID: 19289933
28. Vietnam General Statistics Office. Population and Employment Statistics. Available: http://www.gso. gov. vn/default-en.aspx?tabid=467&idmid=3&ItemID=12941. Accessed 2013 August 14.
29. Nguyen VT, Mclaws M, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. Hepatology 2010;22(2007):2093-2100. doi: 10.1111/j.1440-1746.2007.05010.x
30. Nguyen VTT, McLaws M-L, Dore GJ. Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol. Int. 2007;1(3):387-93. doi: 10.1007/s12072-007-9008-3 PMID: 19669334
31. Sy T, Jamal MM. Epidemiology of Hepatitis C Virus (HCV) Infection. 2006;3(2):41-46. PMID: 16614741
32. Nguyen TTM, Nguyen LT, Pham MD, Vu HH, Mulvey KP. Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Adv. Prev. Med. 2012;2012:732484. doi: 10.1155/2012/732484 PMID: 23227351
33. Few addicts get methadone relief in Vietnam. Asia News Network. http://www.asianewsnet.net/news-68034.html. Published 2014 November 24.
34. Vietnam Ministry of Health. Evaluation of the Epidemiological Impact of Harm Reduction Programs on HIV in Vietnam.; 2011.
35. Vietnam Ministry of Health. National Strategy on HIV/AIDS Prevention and Control: 2010-2020.; 2010.
36. Anderson JP, Tchetgen Tchetgen EJ, Lo Re V, et al. Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation Among HIV- and Hepatitis C Virus-Coinfected Veterans. Clin. Infect. Dis. 2013:1-9. doi: 10.1093/cid/cit779
37. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents.; 2013. Available: http://www.ncbi.nlm.nih.gov/pubmed/12617573.
38. Sy BT, Ratsch B A, Toan NL, et al. High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam. PLoS One 2013;8(10):e78094. doi: 10.1371/journal.pone.0078094 PMID: 24205106
39. Centers for Disease Control and Prevention. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U. S. Department of Health and Human Services. MMWR. Recomm. Rep. 2012;61(RR-5):1-40. Available: http://www.ncbi.nlm.nih.gov/pubmed/23135062.
40. World Health Organization. WHO, UNODC, UNAIDS Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users.; 2009. doi: 10.1016/j.drugpo.2007.12.002 PMID: 18243681
41. Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIVpositive individuals in the D: A: D Study. AIDS 2010;24(10):1537-48. doi: 10.1097/QAD. 0b013e32833a0918 PMID: 20453631
42. Taylor LE, Swan T, Matthews G V. Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy. Clin. Infect. Dis. 2013;57 Suppl 2(Suppl 2:):S118-24. doi: 10.1093/cid/cit326 PMID: 23884059
43. Sun H-Y, Sheng W-H, Tsai M-S, Lee K-Y, Chang S-Y, Hung C-C. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review. World J. Gastroenterol. 2014;20(40):14598-14614. doi: 10.3748/wjg.v20.i40.14598 PMID: 25356024
44. Centers for Disease Control and Prevention. Guidelines for Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public-Safety Workers A Response to P. L. 100-607 The Health Omnibus Programs Extension Act of 1988. MMWR. Morb. Mortal. Wkly. Rep. Suppl. 38(S-6):3-37. PMID: 22695457
45. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected patient. Clin. Liver Dis. 2003;7(1):179-94. Available: http://www.ncbi.nlm.nih.gov/pubmed/12691466. Accessed 2014 January 19. PMID: 12691466